An announcement from Nuvation Bio ( (NUVB) ) is now available.
On October 7, 2024, Nuvation Bio Inc. will welcome Philippe Sauvage as its new Chief Financial Officer, bringing a wealth of experience from his previous senior roles at Sanofi, including Global Head of Operations and Access. Sauvage’s impressive educational background includes degrees from Panthéon-Sorbonne University and École Polytechnique, supplemented by an advanced civil servant education. His employment package features a $510,000 base salary, up to 45% annual bonus, and a stock option plan, with strong severance and benefits provisions, including full vesting of equity in certain termination scenarios. Sauvage’s appointment is backed by a standard indemnification agreement, with no disclosed familial ties or material interest conflicts within the company.
Find detailed analytics on NUVB stock on TipRanks’ Stock Analysis page.
